[Other] Efficacy and safety of tirzepatide monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial

broski Post time 1 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-06-27 15:50
Reward10points

Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Return to the list